๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Metronidazole in the treatment of metastatic brain tumors

โœ Scribed by Robert Aiken; John M Leavengood; Jae-Ho Kim; Michael DF Deck; Howard T Thaler; Jerome B Posner


Publisher
Springer US
Year
1984
Tongue
English
Weight
460 KB
Volume
2
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

โœฆ Synopsis


We measured the effect of the radiation enhancer metronidazole on patients with metastatic brain tumors undergoing radiation therapy (RT) in a randomized controlled study. Metronidazole was given in a dose of 6 g/m 2 4 h before each of the first 3 doses of RT to the whole-brain. A total of 3000 tad was delivered in 6 doses. Patients were followed by serial neurological examinations and CT scans. The metronidazole group did not differ from the control group when measured in terms of survival, clinical improvement or improvement on CT scan, whether measured 2 months or 6 months following treatment. Nausea and vomiting was a significant side effect, preventing about 10% of patients from completing the treatment. Metronidazole appears to have no substantial radiation enhancing effect on metastatic brain tumors.


๐Ÿ“œ SIMILAR VOLUMES


Whole brain radiotherapy in the treatmen
โœ Sandra S. Vermeulen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 43 KB ๐Ÿ‘ 2 views

Previous prospective and retrospective trials have failed to demonstrate the best treatment approach for patients with brain metastases. As a result, fractionated whole brain radiotherapy (WBRT) has been the mainstay of treatment for several decades. However, with improved surgical techniques and th

Surgical treatment of metastatic brain t
โœ Frederick F. Lang; Raymond Sawaya ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 285 KB ๐Ÿ‘ 2 views

Key elements in the modern surgical treatment of metastatic brain tumors are a firm grasp of criteria for selection of proper surgical candidates and a thorough grounding in the surgical approaches to, and the anatomy of, cerebral metastases. It is important to realize that the presence of multiple

Randomized trial of radiotherapy versus
โœ Harmon J Eyre; Joel D Ohlsen; Jess Frank; Albert F LoBuglio; Joseph D McCracken; ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer US ๐ŸŒ English โš– 358 KB

One hundred sixteen eligible patients with metastatic cancer to the brain were randomized to receive either radiotherapy 3000 rad/!0 fractions (treatment l) or the same radiotherapy plus metronidazole 6 gm/m 2 (treatment 2). One hundred eleven patients were either fully or partially evaluable. The r